ProfileGDS4718 / 204526_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 79% 73% 82% 81% 78% 73% 75% 82% 83% 73% 81% 75% 75% 72% 82% 73% 80% 75% 91% 84% 78% 79% 75% 88% 71% 80% 76% 79% 80% 81% 73% 87% 76% 82% 77% 78% 77% 77% 71% 74% 78% 77% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.2263883
GSM549102patient 115, normal, homogenized [OPG study]7.6468679
GSM549104patient 119, normal, homogenized [OPG study]7.2262573
GSM549108patient 138, normal, homogenized [OPG study]7.9877782
GSM549119patient 077, normal, homogenized [OPG study]7.9358581
GSM549133patient 032, cancer, homogenized [OPG study]7.773378
GSM549139patient 042, cancer, homogenized [OPG study]7.1247273
GSM549099patient 107, normal, homogenized [OPG study]7.2916175
GSM549109patient 139, normal, homogenized [OPG study]8.0625882
GSM549110patient 046, normal, homogenized [OPG study]8.2069683
GSM549114patient 063, normal, homogenized [OPG study]7.1657473
GSM549122patient 082, normal, homogenized [OPG study]7.9710881
GSM549134patient 033, cancer, homogenized [OPG study]7.3765675
GSM549136patient 036, cancer, homogenized [OPG study]7.3838475
GSM549140patient 044, cancer, homogenized [OPG study]7.0573772
GSM549111patient 047, normal, homogenized [OPG study]8.1555982
GSM549113patient 057, normal, homogenized [OPG study]7.177373
GSM549132patient 031, cancer, homogenized [OPG study]7.8306880
GSM549137patient 038, cancer, homogenized [OPG study]7.3583375
GSM549142patient 047, cancer, homogenized [OPG study]8.9270691
GSM549100patient 110, normal, homogenized [OPG study]8.2095984
GSM549107patient 135, normal, homogenized [OPG study]7.6177878
GSM549115patient 068, normal, homogenized [OPG study]7.8800279
GSM549116patient 072, normal, homogenized [OPG study]7.3881475
GSM549120patient 078, normal, homogenized [OPG study]8.8351688
GSM549131patient 030, cancer, homogenized [OPG study]6.9872171
GSM549118patient 074, normal, homogenized [OPG study]7.9168480
GSM549129patient 027, cancer, homogenized [OPG study]7.4625476
GSM549123patient 088, normal, homogenized [OPG study]7.788779
GSM549124patient 006, cancer, homogenized [OPG study]7.7566880
GSM549126patient 015, cancer, homogenized [OPG study]8.0092981
GSM549128patient 025, cancer, homogenized [OPG study]7.2547473
GSM549103patient 117, normal, homogenized [OPG study]8.5971987
GSM549117patient 073, normal, homogenized [OPG study]7.3647976
GSM549138patient 041, cancer, homogenized [OPG study]8.1031482
GSM549141patient 045, cancer, homogenized [OPG study]7.6915977
GSM549130patient 028, cancer, homogenized [OPG study]7.6214178
GSM549101patient 111, normal, homogenized [OPG study]7.4650977
GSM549105patient 128, normal, homogenized [OPG study]7.5481477
GSM549106patient 134, normal, homogenized [OPG study]7.0315471
GSM549112patient 048, normal, homogenized [OPG study]7.2275374
GSM549125patient 011, cancer, homogenized [OPG study]7.5776778
GSM549127patient 024, cancer, homogenized [OPG study]7.6211277
GSM549135patient 035, cancer, homogenized [OPG study]8.6038585